OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope: infection fighter takes on resistant ovarian cancer
Disease control Recruiting nowThis study is testing whether atovaquone, a medication normally used to treat certain infections, can help control ovarian cancer that has stopped responding to standard platinum chemotherapy. It will involve 28 patients with this resistant form of cancer to see if the drug can s…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Could one year of treatment match two for ovarian cancer patients?
Disease control Recruiting nowThis large trial aims to see if one year of maintenance therapy is just as effective as two years for patients with advanced ovarian cancer who have specific genetic changes and responded well to initial chemotherapy. It will test two drugs, olaparib and bevacizumab, which work t…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Scientists test new drug duo to target Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis early-stage study is testing a new combination of two oral drugs, M1774 and ZEN-3694, for women with recurrent ovarian or endometrial cancer. The main goals are to find the safest and most effective dose and to see how well the drugs work together to stop cancer cell growth.…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Scientists build a living library of cancer to unlock treatment secrets
Knowledge-focused Recruiting nowThis study is collecting tissue and blood samples from cancer patients over time to create a research resource called a biobank. Researchers will analyze these samples to understand how cancer changes during treatment and why some treatments stop working. The goal is to help scie…
Matched conditions: OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC